ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,036, issued on Jan. 20, was assigned to TONIX PHARMA Ltd. (Dun Laoghaire, Ireland).
"Synthetic chimeric vaccinia virus" was invented by David Evans (Edmonton, Canada), Ryan Noyce (Edmonton, Canada) and Seth Lederman (Austin, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates in various aspects to a synthetic chimeric vaccinia virus or compositions comprising such viruses, and the development and use of systems and methods for producing such synthetic chimeric vaccinia viruses. The synthetic chimeric vaccinia viruses are well suited, among others, as virus vaccines or to generate an oncolytic response and pharmaceutical formul...